Association of disease duration and PASI response rates at week 12 in patients with moderate-to-severe plaque psoriasis receiving biologics in the real-world psoriasis study of health outcomes (PSoHO)
- Andreas Pinter
- , Kilian Eyerich
- , Antonio Costanzo
- , Alyssa Garrelts
- , Christopher Schuster
- , Can Mert
- , Anastasia Lampropoulou
- , Konstantinos Fotiou
- , Julia Tatjana Maul
- , Kim A. Papp
- Klinikum der J. W. Goethe-Universität
- University of Freiburg
- Karolinska Institutet at Karolinska University Hospital
- Humanitas University
- Humanitas Clinical and Research Center
- Lilly Corporate Center
- Medical University of Vienna
- HaaPACS GmbH
- University Hospital Zurich
- University of Zurich
- Alliance Clinical Trials and Probity Medical Research
- University of Toronto Faculty of Medicine
Publikation: Beitrag in Fachzeitschrift › Artikel › Begutachtung
4
Zitate
(Scopus)